• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection

tetano

Editor, Senior Moderator
Sci Rep. 2019 Nov 4;9(1):15899. doi: 10.1038/s41598-019-52258-7. [h=1]Nanobody-based sandwich reporter system for living cell sensing influenza A virus infection.[/h]
Cao J[SUP]1[/SUP], Zhong N[SUP]2[/SUP], Wang G[SUP]1[/SUP], Wang M[SUP]1[/SUP], Zhang B[SUP]3[/SUP], Fu B[SUP]3[/SUP], Wang Y[SUP]3[/SUP], Zhang T[SUP]1,[/SUP][SUP]3[/SUP], Zhang Y[SUP]1,[/SUP][SUP]3[/SUP], Yang K[SUP]4[/SUP], Chen Y[SUP]5[/SUP], Yuan Q[SUP]6[/SUP], Xia N[SUP]1,[/SUP][SUP]3[/SUP].
[h=3]Author information[/h] 1 State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China. 2 Concordia International School Shanghai, 345 Huangyang Road Pudong, Shanghai, 201206, P.R. China. 3 State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, China. 4 Xiamen International Travel Healthcare Center, Xiamen, China. 5 State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Life Sciences, Xiamen University, Xiamen, 361102, P.R. China. yxchen2008@xmu.edu.cn. 6 State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, 361102, China. yuanquan@xmu.edu.cn.

[h=3]Abstract[/h] The influenza epidemic is a huge burden to public health. Current influenza vaccines provide limited protection against new variants due to frequent mutation of the virus. The continual emergence of novel variants necessitates the method rapidly monitoring influenza virus infection in experimental systems. Although several replication-competent reporter viruses carrying fluorescent proteins or small luciferase have been generated in previous studies, visualizing influenza virus infection via such strategy requires reverse genetic modification for each viral strain which is usually time-consuming and inconvenient. Here, we created a novel influenza A nucleoprotein (NP) dependent reporter gene transcription activation module using NP-specific nanobodies. Our results demonstrated the modular design allowed reporter genes (mNeonGreen fluorescent protein and Gaussia luciferase) specifically expressing to detect intracellular NP protein, and therefore acts as a universal biosensor to monitor infection of various influenza A subtypes in living cells. The new system may provide a powerful tool to analyze influenza A infections at the cellular level to facilitate new antiviral drug discovery. Moreover, this approach may easily extend to develop live-cell biosensors for other viruses.


PMID: 31685871 DOI: 10.1038/s41598-019-52258-7
Free full text
 
Back
Top Bottom